Alphavalue / Divacons | US fund Lone Star, which owns 75% of Novo Banco, formally received takeover offers from both Caixabank and French banking group BPCE. In addition to the buyout offers, Lone ...

We and our 909 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting I Accept enables tracking technologies to support the purposes shown under ...

COPENHAGEN (Reuters) -Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the Danish ...

Novo Nordisk is still a dominant player in a growing industry, and it's still growing in the double-digits, even though it's now arguably priced more like a lower-growth consumer staples company.

Novo Nordisk is pulling the plug on its partnership with Hims & Hers Health over claims that the telehealth company sold fake versions of the pharmaceutical firm's weight-loss drug, Wegovy.

Some tie-ups are proceeding without drama, including BPCE’s recent purchase of 6-billion-euro Novo Banco.

France’s BPCE has agreed a 6.4 billion euros ($7.39 billion) deal to acquire Portugal's Novo Banco, including a 75% stake held by U.S. private equity firm Lone Star, BPCE and Lone Star said on ...